Getty Images v Stability AI — what it means for the future of AI & intellectual property

We explore the potential impact of AI on existing copyright laws and delve into the other IP and cross-border issues that arise from the use of global AI tools.
Talk to us: 0333 004 4488 | hello@brabners.com | Contact us

We explore the potential impact of AI on existing copyright laws and delve into the other IP and cross-border issues that arise from the use of global AI tools.

We explore the UK's evolving stance on AI regulation, spotlighting a proposed bill for a central AI authority.

We explore the main issues that influencers and brands need to consider before entering into partnerships.

The Medicines and Healthcare Products Regulatory Agency (MHRA) is continuing to roll out a suite of reforms designed to modernise oversight, enhance patient safety and support innovation.

The EU Data Act is a regulation designed to reshape the European data economy by establishing harmonised rules for data access, sharing and portability.

Designed to amend the UK’s existing data privacy regime, the DUA Act will affect the UK GDPR, PECR and the Data Protection Act 2018.

The Product Regulation and Metrology Act is ushering in a new era for consumer protection and market oversight, laying the foundations for significant regulatory change.

The European Union Intellectual Property Office (EUIPO) has ushered in a new chapter for design protection with reforms to the legal framework governing design rights.

Our retail law team explore what retailers must do to stay compliant with consumer protection laws, advertising standards and more when looking to capitalise on social commerce.

At the State of Play Conference 2025, leading voices from across the sport sector shared their insights on the topic of sports technology.

The 2025 Spending Review marks a pivotal shift in the UK’s fiscal and industrial strategy, with significant ramifications for companies operating in the health, science & technology and defence sectors.

The Medicines and Healthcare products Regulatory Agency (MHRA) Post-market Surveillance and Vigilance regulations are designed to ensure that new technologies are as safe as possible before hitting the UK market.